Influence
January 9, 2020

Regenstrief VP breaking ground in artificial intelligence education in conjunction with National Academy of Medicine, other partners

Eneida Mendonca, Regenstrief Institute, VP for Research DevelopmentRegenstrief Vice President for Research Development Eneida Mendonca, M.D., PhD, is playing a crucial role in the creation of a groundbreaking publication on artificial intelligence in healthcare from the National Academy of Medicine. The document is viewed as a reference for all stakeholders involved in AI and healthcare. Dr. Mendonca is a co-lead on the chapter considering the tradeoffs and unintended consequences of AI and a co-author on the chapter exploring the deployment of AI in clinical settings. She stresses the importance of carefully monitoring the uses and outcomes after AI implementation to correct any negative consequences and the adoption of general IT governance structures to manage AI.  The publication is called “Artificial Intelligence in Health Care: The Hope, The Hype, The Promise, and The Peril.”

Related News

SNOMED and LOINC logos

LOINC® Ontology expands laboratory content, strengthens global interoperability

INDIANAPOLIS, US and LONDON, UK – Regenstrief Institute and SNOMED International have released LOINC® Ontology 2.82, the latest update

Medications for Alcohol Use Disorder reduce healthcare spending

Medications for Alcohol Use Disorder reduce healthcare spending

Alcohol Use Disorder (AUD) remains a major public health challenge in the United States, contributing to more than 170,000

Split-image of Nicholas Pettit, DO, PhD., and IU's Paul Musey, MD

Low Cancer Screening Rates Among Emergency Department Patients: A Multicenter Retrospective Study.

Published in the journal Cancer investment. Here is a link to the article.  Regenstrief Institute author: Paul I. Musey, M.D., M.S.  The content below